Report of Foreign Issuer (6-k)
February 10 2020 - 8:03AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF
1934
For the month of February 2020
Commission File Number: 001-38764
APTORUM GROUP LIMITED
17th Floor, Guangdong
Investment Tower
148 Connaught Road Central
Hong Kong
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F: Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
On February 10, 2020,
Aptorum Group Limited (the “Company”) issued two press releases regarding certain of its lead projects and drug candidates
under development. Copies of the press releases are attached hereto as Exhibit 99.1 and Exhibit 99.2. We
are also filing this report to disclose the revised power point presentation the Company will use during corporate presentations;
such power point presentation is incorporated herein by reference.
Neither this report,
the press releases, nor the power point presentation attached as exhibits hereto constitute an offer to sell, or the solicitation
of an offer to buy our securities, nor shall there be any sale of our securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or
jurisdiction.
The
information in this Form 6-K, including the exhibits shall not be deemed to be “filed” for the purposes of Section
18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing under the Securities
Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
This Form 6-K is hereby
incorporated by reference into the registration statements of the Company on Form S-8 (Registration Number 333-232591) and Form
F-3 (Registration Number 333-235819) and into each prospectus outstanding under the foregoing registration statements, to
the extent not superseded by documents or reports subsequently filed or furnished by the Company under the Securities Act of 1933,
as amended, or the Securities Exchange Act of 1934, as amended.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
Aptorum Group Limited
|
|
|
|
Date: February 10, 2020
|
By:
|
/s/ Sabrina Khan
|
|
|
Name: Sabrina Khan
|
|
|
Title: Chief Financial Officer
|
EXHIBIT INDEX
3
Aptorum (NASDAQ:APM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aptorum (NASDAQ:APM)
Historical Stock Chart
From Sep 2023 to Sep 2024